Biotechnology company Qitan Tech raised ¥40 million in a funding led by Zhongguancun Collaborative Innovation Investment Fund and followed by Yahui Precision Medical Fund and Baidu Ventures. The investment will be used on R&D of new generation nanopore gene sequencing technology.
Established in September 2016,Qitan Tech uses nanopore gene sequencing technology to develop fast, low-cost and small fourth generation gene sequencing instrument and process chemicals.
South Africa Today